Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROCEPT BioRobotics Corp Director's Dealing 2023

Dec 9, 2023

31665_dirs_2023-12-08_3a04522d-f76b-451f-878a-97c26875155c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2023-12-06

Reporting Person: Nouri Alaleh (EVP, CLO, CORP. SEC.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-06 Common Stock M 6096 $4.52 Acquired 53029 Direct
2023-12-06 Common Stock S 6096 $39.9561 Disposed 46933 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-12-06 Stock Option (Right to Buy) $4.52 M 6096 Disposed 2028-09-27 Common Stock (6096) Direct

Footnotes

F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.95 to $39.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F3: The Stock Option was granted on September 28, 2018 and vested over a four year period.